Nakano, K., Hayakawa, K., Funauchi, Y., Tanizawa, T., Ae, K., Matsumoto, S., . . . Takahashi, S. (2021). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Mol Clin Oncol.
Styl cytowania ChicagoNakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.
Styl cytowania MLANakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..